Synspire Pharmaceuticals Announces First Patient Dosed in Phase 1a Study of SNSP113 in Cystic Fibrosis Posted on October 18, 2017May 10, 2023 by Kathryn Kilroy Continue reading “Synspire Pharmaceuticals Announces First Patient Dosed in Phase 1a Study of SNSP113 in Cystic Fibrosis”
Synspire Pharmaceuticals Novel Glycopolymer Improves Effectiveness of Antibiotics Against Drug-resistant Bacteria Associated with Cystic Fibrosis Posted on July 12, 2017May 10, 2023 by Kathryn Kilroy Continue reading “Synspire Pharmaceuticals Novel Glycopolymer Improves Effectiveness of Antibiotics Against Drug-resistant Bacteria Associated with Cystic Fibrosis”
Toggle navigation
Toggle navigation